docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_anatomy_general_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_anatomy_granular_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_biomarker_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_demographics_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_diagnosis_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_posology_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_response_to_treatment_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_test_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_therapy_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_tnm_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_unspecific_posology_en.md
docs/_posts/mauro-nievoff/2022-09-30-ner_oncology_anatomy_general_wip_en.md
docs/_posts/mauro-nievoff/2022-09-30-ner_oncology_demographics_wip_en.md
docs/_posts/mauro-nievoff/2022-09-30-ner_oncology_diagnosis_wip_en.md
docs/_posts/mauro-nievoff/2022-09-30-ner_oncology_test_wip_en.md
docs/_posts/mauro-nievoff/2022-09-30-ner_oncology_therapy_wip_en.md
docs/_posts/mauro-nievoff/2022-09-30-ner_oncology_tnm_wip_en.md
docs/_posts/mauro-nievoff/2022-09-30-ner_oncology_unspecific_posology_wip_en.md
docs/_posts/mauro-nievoff/2022-09-30-ner_oncology_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-ner_oncology_anatomy_granular_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-ner_oncology_biomarker_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-ner_oncology_posology_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-ner_oncology_response_to_treatment_wip_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_anatomy_general_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_anatomy_granular_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_biomarker_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_demographics_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_diagnosis_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_posology_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_response_to_treatment_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_test_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_therapy_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_tnm_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_unspecific_posology_en.md
docs/en/benchmark.md
docs/en/licensed_install.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_anatomy_general_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_anatomy_granular_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_biomarker_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_demographics_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_diagnosis_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_posology_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_response_to_treatment_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_test_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_therapy_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_tnm_en.md
docs/_posts/Ahmetemintek/2022-11-24-ner_oncology_unspecific_posology_en.md
docs/_posts/mauro-nievoff/2022-09-30-ner_oncology_anatomy_general_wip_en.md
docs/_posts/mauro-nievoff/2022-09-30-ner_oncology_demographics_wip_en.md
docs/_posts/mauro-nievoff/2022-09-30-ner_oncology_diagnosis_wip_en.md
docs/_posts/mauro-nievoff/2022-09-30-ner_oncology_test_wip_en.md
docs/_posts/mauro-nievoff/2022-09-30-ner_oncology_therapy_wip_en.md
docs/_posts/mauro-nievoff/2022-09-30-ner_oncology_tnm_wip_en.md
docs/_posts/mauro-nievoff/2022-09-30-ner_oncology_unspecific_posology_wip_en.md
docs/_posts/mauro-nievoff/2022-09-30-ner_oncology_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-ner_oncology_anatomy_granular_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-ner_oncology_biomarker_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-ner_oncology_posology_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-ner_oncology_response_to_treatment_wip_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_anatomy_general_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_anatomy_granular_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_biomarker_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_demographics_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_diagnosis_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_posology_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_response_to_treatment_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_test_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_therapy_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_tnm_en.md
docs/_posts/mauro-nievoff/2022-10-25-ner_oncology_unspecific_posology_en.md
docs/en/benchmark.md
docs/en/licensed_install.md
